Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years' experience.
Wakamatsu K, Kageshita T, Furue M, Hatta N, Kiyohara Y, Nakayama J, Ono T, Saida T, Takata M, Tsuchida T, Uhara H, Yamamoto A, Yamazaki N, Naito A, Ito S.
Wakamatsu K, et al. Among authors: uhara h.
Melanoma Res. 2002 Jun;12(3):245-53. doi: 10.1097/00008390-200206000-00008.
Melanoma Res. 2002.
PMID: 12140381